Call us at (888) 828-2206. We'll help answer any questions you may have.
CART-ddBCMA is a BCMA directed CAR T cell therapy in development for multiple myeloma.
View all active clinical trials around the US.
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
March 12, 2020
You can give us a call at (888) 828-2206 or create your account to add this treatment to your list of favorites. We'll send you alerts when this treatment is updated.
Create My Account